Capital Performance Advisors LLP Abbott Laboratories Transaction History
Capital Performance Advisors LLP
- $597 Million
- Q3 2025
A detailed history of Capital Performance Advisors LLP transactions in Abbott Laboratories stock. As of the latest transaction made, Capital Performance Advisors LLP holds 4,124 shares of ABT stock, worth $525,974. This represents 0.09% of its overall portfolio holdings.
Number of Shares
4,124
Previous 4,987
17.3%
Holding current value
$525,974
Previous $678,000
18.58%
% of portfolio
0.09%
Previous 0.13%
Shares
5 transactions
Others Institutions Holding ABT
# of Institutions
3,609Shares Held
1.4BCall Options Held
9.23MPut Options Held
8.1M-
Vanguard Group Inc Valley Forge, PA173MShares$22 Billion0.39% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.7 Billion0.31% of portfolio
-
State Street Corp Boston, MA78.4MShares$9.99 Billion0.41% of portfolio
-
Capital International Investors Los Angeles, CA60.1MShares$7.67 Billion1.47% of portfolio
-
Capital Research Global Investors Los Angeles, CA41.8MShares$5.33 Billion1.19% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $223B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...